• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

FDA rejection

Eylea HD
Pharma

Regeneron's Eylea franchise stumbles on several fronts in Q1

After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull down the drugmaker.
Fraiser Kansteiner Apr 29, 2025 2:50pm
red light stop light street traffic signal

Lexicon gets final FDA rejection for diabetes prospect

Dec 23, 2024 11:20am
Image of a neon sign with the word no lit up next to an unlit yes

J&J, AZ approval filings rejected by FDA

Dec 17, 2024 10:02am
Graphic of a fork in the road with arrows pointing in either direction

Lexicon steps out of commercial space after FDA setbacks

Nov 22, 2024 11:46am
Image of a neon sign with the word no lit up next to an unlit yes

FDA shoots down Intercept's bid for full approval of Ocaliva

Nov 12, 2024 2:12pm
CRL complete response letter rejection FDA rejection

Zealand's hypoglycemia med rebuffed again by FDA

Oct 9, 2024 9:19am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings